Found 21 matching trials
40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) PHASE3 Bipolar disorder is characterized by mood swings that range from from high ...
Show More Location
Multiple Locations
Learn More & Join Trial
12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017) PHASE3 This is a 12-week study that will test the safety and efficacy of asenapine...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) PHASE3 The primary features of schizophrenia and schizoaffective disorder are posi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder PHASE4 This is an open-label pilot study of adjunctive asenapine for the treatment...
Show More Location
Tuscaloosa VA Medical Center
Learn More & Join Trial
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) PHASE3 Treatment with conventional antipsychotics such as haloperidol has little e...
Show More Location
Multiple Locations
Learn More & Join Trial
40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) PHASE3 The primary objective of this trial was to characterize the long-term (up t...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) PHASE3 This study evaluates the safety and tolerability of Asenapine in elderly pa...
Show More Location
Multiple Locations
Learn More & Join Trial
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) PHASE3 A multicenter, randomized, parallel-group, double-blind, fixed dose, 6-week...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) PHASE3 This is a multi-site, open-label fixed-flexible dose long-term study of ase...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692) PHASE3 Participants who have completed the 3-week trial P05691 (NCT00764478) can b...
Show More Location
Forest Investigative Site 1000
Learn More & Join Trial